A KPMG survey of 190 device maker financial executives finds 61% of respondents expect the 2.3% medical device tax to negatively affect their firms' bottom lines, and 40% are considering price increases and layoffs to offset the levy. AdvaMed has raised concerns that the tax would shift jobs overseas and hurt innovation, and legislators have pushed for its repeal.

Full Story:

Related Summaries